| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d709e3167fa2f99a1803c9cfeb0aca63 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D457-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D457-06 |
| filingDate |
1981-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_172b13936f0a881a96df8fd78e5fc8e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f691fdf716b95e95b92ba0fffc592aa6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_275212500fc4efe80d76db84605892db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_431a9d09be85b8d877ff911aca879c11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e144fdccc9be3e161c7489e226d3cd9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe6ad5bf92a9e8a04d2fee8de3a9fb56 |
| publicationDate |
1981-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
FR-2479829-A1 |
| titleOfInvention |
ERGOLINE-DERIVED COMPOUNDS, PROCESS FOR PREPARING THEM AND THEIR USE AS MEDICAMENTS |
| abstract |
COMPOUNDS DERIVED FROM ERGOLINE, PROCESS FOR THE PREPARATION AND THEIR USE AS MEDICINAL PRODUCTS. THESE COMPOUNDS MEET FORMULA I: (CF DRAWING IN BOPI) IN WHICH R REPRESENTS A HYDROGEN ATOM OR A METHYL GROUP; R REPRESENTS A HYDROGEN ATOM OR A HALOGEN ATOM, A METHYL OR FORMYL GROUP OR A GROUP OF FORMULA S-R OR SO-R IN WHICH R REPRESENTS AN ALKYL GROUP HAVING 1 TO 4 CARBON ATOMS OR A PHENYL GROUP; R REPRESENTS A HYDROGEN ATOM OR A METHOXY GROUP; R REPRESENTS A HYDROCARBON GROUP HAVING 1 TO 4 CARBON ATOMS, A BENZYL OR PHENETYL GROUP; R AND R EACH INDEPENDENTLY REPRESENT A CYCLOHEXYL GROUP OR A SUBSTITUTE OR INSUBSTITUTE PHENYL GROUP, OR A GROUP SOLUBLE IN ACID AND IN WATER SUCH AS (CH) N (CH) IN WHICH N IS A WHOLE NUMBER, WITH THE CONDITION THAT R AND R DO NOT REPRESENT AT THE SAME TIME THE ACID AND WATER SOLUBLE GROUP. THESE COMPOUNDS AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS ARE USEFUL AGAINST HYPERTENSION; THEY HAVE ANTIPROLACTINIC AND ANTITUMOR ACTIVITY MAINLY AGAINST TUMORS THAT DEPEND ON PROLACTIN. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2083008-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2067780-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4713457-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009071607-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7186837-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7339060-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009071607-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7238810-B2 |
| priorityDate |
1980-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |